The IAB logo The Institute for Applied Biomedicine
The Institute for Applied Biomedicine


 

Institute for Applied Biomedicine is developing drugs to treat immune system diseases including AIDS. The Institute is a not-for-profit biotechnology firm committed to making our drugs accessible to all.

Frequently Asked Questions
Background information for the Institute
Non-Sugar Treats for Halloween • 2001 UARP Poster


AIDS
We are in pre-clinical testing for a new AIDS drug, which is designed to keep the immune system of an HIV-positive person healthy. Initial test results have been clearly positive.
    Autoimmune Diseases
We are developing treatments for autoimmune diseases such as rheumatoid arthritis and lupus. We have filed for patent protection on our broad, immune-modifying technology.
  • Overview - an overview of our organization and research, with links to more detailed information.
  • Product Pipeline - the Institute's drugs for immune system diseases other than AIDS; drug development plans.
  • Our AIDS Drug: Immudel™-gp120 - the Institute's experimental AIDS drug; results of pilot tests; drug development plans; the Institute's Medical Hypotheses article and references; expert review; general information about AIDS; AIDS-related annotated links. Information on both non-technical and technical levels.
  • Support Our Research - on-line and off-line donations, volunteering, and other opportunities to support our research and drug development; confidential mailing list.

Please Contact Us via email, phone, fax, or mail with questions, comments, or tax-deductible contributions.

This web site designed and maintained by Michael Toppa

© 1997-2009 Institute for Applied Biomedicine. All Rights Reserved. Legal Notices.